Clinical Trials · NCT02621736
Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University Hospital, Basel, Switzerland
- Enrollment
- 28
- Start date
- Jan 2016
- Locations
- 1 site, Switzerland
- Primary endpoint
- Change of copeptin at baseline and after 28 days during routine desmopressin therapy